Foreword
New Pharma Business Models
Regaining power
Changing patterns of diseases ageing population price controls dry RD pipelines patent expirations for many blockbuster drugs and declining global generic market opportunities are a wakeup call for pharma Moreover the shift in focus to improved outcomes is pushing pharma companies to rethink on the existing business models for more productive RD so...
Partnerships
A pill for growth
The pharma industry is treading a new path for sustaining growthpartnerships Escalating RD costs tough regulations and price controls continue to trouble the industry Further a severe blockbuster drought patent expiries and anaemic drug pipelines have only added to the industrys woes Innovation did provide hope but even that has become a high
